Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 5101-5150 of 6048 result(s).
CYDY CytoDyn Inc
06/20/2020 5:12:22 PM
That's the Pestell paper I've read
CYDY CytoDyn Inc
06/20/2020 5:08:28 PM
Laundry, IMHO, a buyout is a fore g (6)
CYDY CytoDyn Inc
06/19/2020 10:54:45 AM
Dr. Patterson wouldn't have even ne (4)
CYDY CytoDyn Inc
06/18/2020 5:17:28 PM
One of the main anti-inflammatory a (3)
CYDY CytoDyn Inc
06/18/2020 7:03:35 AM
Amyotrophic lateral sclerosis was s (1)
CYDY CytoDyn Inc
06/18/2020 12:31:27 AM
Why would you assume that rather th (1)
CYDY CytoDyn Inc
06/17/2020 11:19:09 PM
activated microglia induced recruit (2)
CYDY CytoDyn Inc
06/17/2020 6:17:57 PM
So far, the public has done an exce (1)
CYDY CytoDyn Inc
06/16/2020 10:43:16 AM
Only a small bit of the actual tria (1)
CYDY CytoDyn Inc
06/16/2020 9:38:15 AM
With Dexamethasone using the sparse (4)
CYDY CytoDyn Inc
06/16/2020 9:22:19 AM
If we hit $20 billion total revenue (10)
CYDY CytoDyn Inc
06/16/2020 5:48:34 AM
Spot on. I've been pointing that ou (4)
CYDY CytoDyn Inc
06/15/2020 11:11:13 AM
The beauty of leronlimab is that it (16)
CYDY CytoDyn Inc
06/15/2020 11:07:58 AM
As a GM-CSF inhibitor it will be mi (4)
CYDY CytoDyn Inc
06/15/2020 10:58:51 AM
After COVID-19 approval we'll have (3)
CYDY CytoDyn Inc
06/15/2020 8:53:25 AM
I wonder if they've checked for pan (3)
CYDY CytoDyn Inc
06/15/2020 2:39:23 AM
I'm here to try to rile you up You (1)
CYDY CytoDyn Inc
06/14/2020 5:04:38 PM
Both of you will be the Jed Clampet (5)
CYDY CytoDyn Inc
06/14/2020 4:59:06 PM
Transmission can occur with a limit (1)
CYDY CytoDyn Inc
06/14/2020 11:07:32 AM
It's not the significance of RANTES (2)
CYDY CytoDyn Inc
06/12/2020 6:58:17 AM
Das sind phantastische News. (1)
CYDY CytoDyn Inc
06/12/2020 1:54:16 AM
Don't worry I've more than made up (3)
CYDY CytoDyn Inc
06/11/2020 8:34:08 PM
Using a drug off label is not an FD (5)
CYDY CytoDyn Inc
06/11/2020 6:42:33 PM
It sounds like we’re going with a
CYDY CytoDyn Inc
06/11/2020 6:31:45 PM
Neuroinflammation, the accompanying (5)
CYDY CytoDyn Inc
06/11/2020 1:24:54 PM
Guillain-Barre Syndrome is on the l
CYDY CytoDyn Inc
06/10/2020 2:25:30 PM
that doesn't say BP. Previously, Dr (1)
CYDY CytoDyn Inc
06/10/2020 1:09:11 PM
Did I miss where either of them had (2)
CYDY CytoDyn Inc
06/10/2020 12:41:45 PM
Any more questions? No, but I do ha (9)
CYDY CytoDyn Inc
06/10/2020 11:16:04 AM
I wonder if introduction of an angi (2)
CYDY CytoDyn Inc
06/10/2020 10:46:36 AM
The sales rep channel is the one bi (2)
CYDY CytoDyn Inc
06/09/2020 6:25:02 AM
The question to ask is why an addit
CYDY CytoDyn Inc
06/09/2020 6:05:47 AM
It sounds like she suffered irrever (2)
CYDY CytoDyn Inc
06/09/2020 2:47:28 AM
When it comes to HIV it is an antiv
CYDY CytoDyn Inc
06/07/2020 9:46:37 AM
IL-6 only blah,blah, blah (2)
CYDY CytoDyn Inc
06/07/2020 7:04:03 AM
Then I suggest you have a large unm (2)
CYDY CytoDyn Inc
06/06/2020 6:45:04 PM
Sweden's cases are still on the ris
CYDY CytoDyn Inc
06/05/2020 8:22:35 AM
It's based on the 2 to 1 ratio.
CYDY CytoDyn Inc
06/05/2020 3:47:13 AM
Disease progression COVID-19 In the (8)
CYDY CytoDyn Inc
06/05/2020 2:11:58 AM
It's been shown that an overactive (3)
CYDY CytoDyn Inc
06/04/2020 9:40:41 AM
Lenzulimab is a GM-CSF inhibitor, w (3)
CYDY CytoDyn Inc
06/04/2020 8:29:59 AM
On another topic, am I the only one (7)
CYDY CytoDyn Inc
06/04/2020 7:34:46 AM
If the patient has tried all approv
CYDY CytoDyn Inc
06/04/2020 7:10:04 AM
Same ISIN number which I believe wo (1)
CYDY CytoDyn Inc
06/03/2020 9:23:29 PM
For now Right to Try would be the o (2)
CYDY CytoDyn Inc
06/03/2020 10:22:28 AM
In the short term good for them. In (5)
CYDY CytoDyn Inc
06/03/2020 9:48:52 AM
Aji Bio-Pharma provides high qualit
CYDY CytoDyn Inc
06/02/2020 10:58:46 AM
I like NP but current trading is a
CYDY CytoDyn Inc
06/02/2020 8:43:18 AM
New 8K - Having an independent chai (4)
CYDY CytoDyn Inc
06/02/2020 7:13:29 AM
JAK inhibitor, which leronlimab als (1)
Go to page:
  • << First
  • < Previous
  • 102
  • 103
  • Next >

Recent Articles

  • Top Electrical Equipment Stocks Experience Momentum Surge
  • MT Højgaard Danmark Takes Charge of Exciting Metro Expansion
  • Key Stocks Making Waves: Intel, FedEx, Cracker Barrel Insights
  • Investors of Jasper Therapeutics Face Class Action Insights
  • Charter Communications Faces Legal Challenges Amid Stock Drop
  • Legal Update on Lineage, Inc.: Investor Class Action Lawsuit
  • Investors of RxSight, Inc.: Understanding Your Legal Rights
  • Exploring Innovations at the 2025 International Consumer Electronics Expo
  • Jiangbei New Area's Global Initiative for Talent Development
  • XRP Tundra's Innovative Dual Token System Boosts Market Interest
  • BloFin Strengthens Security with PCI DSS Certification Achieved
  • Unlocking Digital Transformation: Huawei's 30+ Global Showcases
  • H World Expands JI Hotel Brand into New Markets of Southeast Asia
  • Overtake Marketplace Integrates World ID for Enhanced Security
  • AI Deepfakes in Indian College Elections: A New Trend Emerges
  • Trump's $15 Billion Lawsuit Against NYT Dismissed by Judge
  • Comprehensive Guide to Announcing Company Updates
  • Ray Dalio Highlights Danger of U.S. Debt Crisis Amid Growing Concerns
  • Concerns Rise as Russian Jets Intrude on NATO Airspace
  • Tesla Extends Robotaxi Tests to Arizona, Eyeing Nationwide Reach
  • Erik Siebert's Resignation Amid Pressure from Trump Administration
  • Intel's Future: A Call to Go Private and Compete in Tech
  • Elon Musk's Tesla Compensation Plan Sparks Heated Debate
  • Mark Zuckerberg on AI Spending: Opportunities Amid Risks
  • Social Security Chief Clarifies Retirement Age Comments
  • Pony.ai Launches Innovative Autonomous Vehicle Services in Singapore
  • Pony.ai Enhances Mobility Solutions with Singapore Launch
  • Xinjiang's Growth: A Bright Future Awaits Under New Strategies
  • Nexstar Broadcasting Faces Legal Action Over Labor Violations
  • Celebrating Victory: The Inaugural Más+ by Messi Tournament
  • Josys Earns Spot in 2025 Gartner Magic Quadrant for SaaS
  • V.F. Corporation Legal Action: Investors' Compensation Opportunities Await
  • Easterly ROCMuni Fund Investors Urged to Act Before Deadline
  • Important Update for Fiserv Investors on Class Action Timeline
  • Secure Your Rights as a Flywire Investor Amid Ongoing Case
  • New Visa Fee Could Shift Tech Workforce Dynamics in US
  • FAIR Advocates for Immigration Reform Through Executive Orders
  • Huawei Introduces Revolutionary Pathway and Solutions for AI
  • BNC's $250 Million Stock Buyback: A Strategic Move Forward
  • Investors Should Act Quickly: Luminar Technologies Guidance
  • Snap Inc. Shareholder Alert: Class Action Lawsuit Update
  • Investors Alert: Key Information on Dow Inc. Class Action
  • Understanding the Legal Landscape: C3.AI Investor Insights
  • Fluor Corporation Lawsuit Update: Your Rights as an Investor
  • V.F. Corporation Class Action Lawsuit and Shareholder Rights Explained
  • Kahn Swick & Foti Expands Investigation into Five Below Executives
  • Investigation Launched into Microvast's Leadership Practices
  • Concerns Grow Over Pentagon's Restrictions on Journalists
  • Investors Urged to Act on Sable Offshore Class Action Rights
  • SelectQuote Investor Alert: Class Action Deadline Approaches
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site